TPG buys Asian pathology operations of Australia's Healthscope for $206m

Australian healthcare provider Healthscope has sold its Asian pathology operations to private equity group TPG Asia for A$279 million ($206 million), it said in a disclosure to the Australian Securities Exchange (ASX).